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A majorissue in transplantation immunology is the nature ofthe cellular interac-
tions and responses involved in in vivo responses to tissue allografts. In previous
work, we demonstrated that skin allograft rejection is initiated and mediated only
by T cell populations that contained both lymphokine-secreting T helper (Th)t cells
and cytolytic T effector (Teff) cells reactive against the alloantigens ofthe graft (1).
We further showed that skin allograft rejection could result from interactions be-
tween Th cells and Tefr cells of different Lyt phenotypes and of different antigen
specificities (1). The present study specifically addresses the cellular pathways and
interactions involved in the rejectionofMHC class I disparate grafts. Though rejec-
tion of MHC class I disparate skin grafts can result from an interaction between
L3T4+ class II-specific Th cells and Lyt-2+ class I-specific Test cells, rejection of
MHC class I disparate grafts can also be mediated by isolated Lyt-2+ T cell popu-
lations (1-3). However, uncertain in this latter mechanism is whether the Th and
Teff cellular functions, contained within the isolated Lyt-2` T cell population and
requisite to reject class I disparate skin allografts, are mediated by functionally dis-
tinct populations of Th and Teff cells or by single populations of dual-function
Th/Tef cells (4-6). To address these two possibilities, we tested whether class
I-specific Th cells provided help in vivo for the activation ofphysically distinct popu-
lations of Teff cells capable of rejecting skin allografts.
In the present study, we show that class I-reactive T cells reject skin allografts
for which they are specific, but, unlike class II-reactiveTcells, fail to generate help
for the rejection of third-party skin allografts. Nevertheless, Class I-allospecific Th
cells do recognize and respond to class I allodeterminants expressed on skin grafts,
but the responding Tcells consume nearly all ofthe lymphokine produced. These
findings aremostconsistentwiththe participation in anti-class I rejection responses
ofdual-function Th/Teffcells that consume the helper lymphokines that they secrete.
A. S. Rosenberg is the 1986 recipient of the American Society ofTransplant physicians-Sandoz Fellow-
ship in Transplantation. Address correspondence to A. S. Rosenberg, National Institutes of Health,
Bldg. 10, Rm. 41117, Bethesda, MD 20892.
t Abbreviations used in this paper: MST, median survival time; Tea, T effector; Th, T helper.
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MECHANISMS OF CLASS I ALLOGRAFT REJECTION
Materials and Methods
Mice.
￿
B10 nu/nu female mice were obtained from the Small Animal Section, National In-
stitutes of Health, Bethesda, MD. C57BL/6 (B6) and C57BL/10 (B10) mice were obtained
from The Jackson Laboratory, Bar Harbor, ME. B6.Tlaa breeder mice were a generous gift
of Dr. L. Flaherty, Albany, NY (7). B10.QBR, B6.C-H-26m' (bml) (8), B6.C-H-26`"'2 (bm12)
(9), B6.C-H-26'"6 (bm6) (10), and Fi mice were bred in our own animal facility.
mAbs.
￿
Anti-L3T4 mAb was either aculture supernatant of the hybridoma cell line GK1.5
(11) or was an ascites ofthe hybridoma cell line RL-172/4 (12). Anti-I-A6 mAb was a culture
supernatant ofthe hybridoma cell line M5/114 (13). Rat anti-murine IL-2-R mAb was a mouse
ascites of the hybridoma cell line 7134 (14).
Cell Fractionation.
￿
Depletion of L3T4' T cells was accomplished by incubating spleen cells
at a density of 10' cells/ml with anti-L3T4 (1 :2 dilution of GK1.5 or a 1 :100 dilution of RL-
172/4) mAb for 30 min at 4°C. Cells were then pelleted, resuspended, and incubated with
complement for 50 min at 37'C. The cells treated with GK1 .5 were resuspended at 107/ml
in low toxicity rabbit complement (Cedar Lane, Ontario, Canada) diluted 1 :10. The cells
treated with RL-172/4 were resuspended at 108/ml in Guinea pig complement (Gibco
Laboratories, Chagrin Falls, OH) diluted 1 :3. Treated cells were washed three times before
injection into experimental animals or placement in culture as indicated.
Skin Grafting ofNormal B6Mice and B10 nu/nu Mice.
￿
Mice were engrafted on the left thorax
with two tailskin grafts, separated by a host skin bridge, according to an adaptation of the
method of Billingham and Medawar (15) . Bandages were removed on day 7, and the grafts
were scored daily until rejection or the end point of the experiment.
Adoptive Transfer.
￿
Female B10 nude mice were engrafted as above. On day 1, the mice were
injected intravenously with 5 x 107 spleen cells from unprimed female B6 mice that had been
untreated or treated with anti-L3T4 antibody and complement. Bandages were removed on
day 7, and the grafts were scored daily until rejection or the end point of the experiment.
This adoptive transfer model has been described in detail elsewhere (1).
Culture Conditions.
￿
Responder and stimulator populations were obtained either from primed
or unprimed mice as indicated. Spleen stimulator cells were irradiated with 2,000 rad. Re-
sponder populations were depleted ofadherent accessory cells by passage over Sephadex G-10
columns (16). Responder spleen cells (4 x 105) and stimulator spleen cells (4 x 105) were
cultured together for 4 d in 0.2 ml of culture medium at 37°C in 7.5% C02, as previously
described (16), unless otherwise indicated. Where indicated, 0.01 17o ascites of anti-IL-2-R
mAb, 7134, was added to each culture to inhibit the consumption of IL-2 during the response
period (17). On day 4 of culture, 0.1 ml of supernatant was obtained from each well and as-
sayed by its ability to maintain the growth of an IL-2-dependent cell line, HT -2 (18). Control
experiments showed that the IL-2 content of the supernatants from these response cultures
reached a plateau on day 4. After 24 h, cultures of HT-2 cells were pulsed with luCi of
[3H]thymidine, incubated for an additional 12-18 h, then harvested. Background counts of
HT-2 cells pulsed with medium alone varied between 200 and 1,200 cpm; maximum counts
of HT-2 cells pulsed with an excess ofIL-2 varied between 60,000 and 80,000 cpm. The con-
centration of IL-2 present in the culture supernatants was always limiting, in that the HT-2
response they stimulated always declined in a log-linear fashion as the culture supernatants
were diluted. Data are expressed as the arithmetic mean counts per minute of triplicate or
quadruplicate cultures. Data as presented are the actual counts obtained and have not been
corrected for HT-2 background counts. SE were generally <5To of the mean and so have not
been included in the tables.
Results
Failure ofMHC Class IAlloantigens to Function In Vivo as Helper Determinantsfor Third-
party Rejection Responses. We have previously demonstrated that most B6 mice must
recruit Th cells with additional recognition specificities in order to initiate rejec-
tion responses against either Kbm6 or Qa-1a disparate tailskin allografts (1, 3). To
assess the ability of MHC class I allodeterminants to function as in vivo helper de-ROSENBERG ET AL.
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terminants for the initiation of rejection responses against third-party bm6 or Qa-
1a skin allografts, we engrafted normal B6 mice with two skin grafts: an "indicator"
graft on the lower part of the flank expressing only the target antigen; and an "in-
ducer" graft on the upper part of the flank expressing both the target antigen and
putative helper determinants. We then assessed the ability of the inducer graft to
promote rejection of the indicator graft. In Table I, we examined the ability of in-
ducer grafts expressing various helper determinants to initiate rejection of bm6 in-
dicator grafts. It can be seen that inducer grafts expressing only target Kbm6 antigens
failed to induce rejection of bm6 indicator grafts (group 1). However, (bm6 x
bml2)F1 inducer grafts expressing both target Kbm6 antigens andIbm12 determinants,
but not (B10 x bml2)Fl inducer grafts expressing Ibm12 determinants alone, initi-
ated efficient rejection of indicator bm6 grafts (groups 2 and 3). Thus, consistent
with our previous observations (1), MHC class II Ibm12 allodeterminants were able
to elicit T cell help necessary for the local activation of anti-Kbms effector cells medi-
atingthe rejectionofbm6indicator skin allografts. More importantly, we also tested
the ability of MHC class I (Kbm1) allodeterminants to function as in vivo "helper"
determinants for this in vivo rejection response. We did so by using (bm6 x bml)Fl
skin as the inducer graft so that it would express both Kbms target antigens as well
as putative Kbml helper determinants. Expression of Kbm1 allodeterminants by the
inducer graft provided a potent rejection stimulus as demonstrated by the rapid re-
jection ofthe inducer graft itself (group 4). However, expression by the inducergraft
of Kbm1 class I allodeterminants failed to initiate a significant rejection response
against the bm6 indicator graft (group 4). Similar results were obtained with (bm6
x bm10) inducer grafts expressing Kbm1o class I allodeterminants (data not shown).
Thus, unlike MHC class11 alloantigens, MHC class I alloantigens failed to generate
help for the initiation of third-party anti-Kbm6 rejection responses.
In Table 11, we reassessed the ability of Kbm1 class I allodeterminants to function
as in vivo helper determinants using Qa-1 a disparate skin allografts from B6.Tlaa
mice as the indicator grafts. Inducer grafts expressing only Qa-1a target antigens
failed to induce rejection of Qa-la indicator grafts (group 1), whereas inducer grafts
expressing both Qa-l a target antigens and Ibm12 helper determinants did induce re-
jection of Qa-1a indicator grafts (group 2). However, inducer grafts expressing both
Qa-1a target antigens and Kb-1 class I allodeterminants, despite being highly im-
munogenic as indicated by rejection of the inducer grafts themselves, failed to ini-
tiate rejection of the Qa-la indicator grafts (group 3). Thus, MHC class I Kb-1 al_
lodeterminants also failed to generate help forthe initiation of anti-Qa-la rejection
responses.
PresenceofMHC ClassIAllodeterminants Does not Suppress theRejection ofIndicatorSkin
Grafts Bearing Third-party K` Determinants. We think that K` allodeterminants
expressed by skin grafts fail to induce the rejection of skin grafts expressing third-
party Kbm6 or Qa-1a determinants because they fail to elicit sufficient T cell help
for the activation of Kbm6_ or Qa-la-specific Teff cells. However, an alternative pos-
sibility is that the response to Kb ` allodeterminants generatescells capable of down
regulating the response to third-party alloantigens. To test this possibility, we as-
sessed whether mice that had retained indicator bm6 skin grafts despite rejecting
inducer (bm6 x bml)F1 grafts could subsequently reject these indicator grafts if
provided with aproven source of T cell help. Therefore, we engrafted B6 mice with36 MECHANISMS OF CLASS I ALLOGRAFT REJECTION
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FIGURE 1.
￿
Survival of bm6 indicator grafts as a func-
tion of inducer graft placement. On day 0, mice were
engraftedwith bm6indicatorgrafts and inducer grafts
from (bm6 x bml)F7 mice (O), (bm6 x bm12)F7 mice
(0), or bm6 mice (A). Not shown in the graph is that
thesefirst inducer grafts were rejected as follows: 9/9mice
rejected (bm6 x bml)F, grafts, MST 17 d; 9/9 mice re-
jected (bm6 x bml2)F7 grafts, MST 14 d;and 1/10 mice
rejected bm6grafts, MST>71 d. On day 71, mice were
regrafted with skin from (bm6 x bm12)F7 mice as a
second inducer graft. Rejection of the original bm6in-
dicator grafts is shown as a function of time in days.
(bm6 x bm1)Ft inducer and bm6 indicator grafts. As seen in Fig. 1, mice engrafted
with inducer grafts expressing both bm6 and bml determinants failed to reject their
bm6 indicator grafts in 71 d despite rejection of the (bm6 x bm1)Ft inducer grafts
(median survival time (MST) 17 d, data not shown). To test whether mice engrafted
with (bm6 x bml)Fi inducer grafts were consequently rendered incapable of re-
jecting bm6 indicator grafts, we regrafted them on day 71 with a second inducer
graft. Mice engrafted with (bm6 x bml2)Ft skin as a second inducer graft rejected
their original bm6 indicator grafts with a MST of 12 d (Fig. 1). This rejection rate
of bm6 indicator grafts was similar to that induced by (bm6 x bml2)Ft inducer
grafts on naive mice (MST of 12 d). Thus, inducer skin grafts expressing MHC
class I Kbmt allodeterminants as well as Kbm6 target determinants did not generate
functionally detectable Kbm6-specific suppression.
Failure ofLyt-2' T Cells to Generate Helpfor In Vivo Rejection of Third-party Allografts.
We next considered the, possibility that L3T4' T cells present in normal engrafted
mice might have interfered with the helper function of MHC class I-allospecific T
cells. Consistent with such a possibility is the observation that mice reconstituted
with isolated populations of Lyt-2' T cells frequently reject class I disparate skin
allografts more rapidly than mice reconstituted with T cell populations containing
both Lyt-2' and L3T4' T cells (3). To examine the ability of MHC class I K"
allodeterminants to function as in vivo helper determinants in the absence of L3T4'
T cells, we adoptively transferred unfractionated or L3T4- spleen cells into B10
nude mice that had been engrafted with both inducer and indicator skin allografts
(Table III). We used the male H-Y antigen as the target antigen in this experiment
because effector cells mediating the anti-HY rejection response are Lyt-2' and re-
quire additional help (1, 19). Indeed, mice reconstituted with isolated Lyt-2' T cells
failed to reject HY disparate B6 male indicator grafts .(Table III, group 1). More
importantly, such mice failed to reject HY disparate indicator grafts even when en-
grafted with inducer grafts expressing both the HY target antigens and Kb"1t al-
lodeterminants (Table III, group 2). These mice did, however, reject the Kbmr_MECHANISMS OF CLASS I ALLOGRAFT REJECTION
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FIGURE 2.
￿
Response of L3T4-, Lyt-2' lymphokine-secreting
T cells from B6 mice engrafted with bml skin allografts. B6
responderspleen cells were depleted of adherent cells by pas-
sage over a Sephadex-G10 column andthen treatedwith anti-
L3T4 mAband Gto deplete L3T4' Tcells. Respondercells
from naive B6 mice (open symbols) or B6 mice that had been
engrafted with and had rejected bml skin allografts (closed
symbols) were cultured with spleen stimulator cellsfrom either
bml (O, ") or H-2D9 expressing B10.QBR (0, E) mice.
Each response culture contained anti-IL-2-R mAb(0.01% of
7D4 ascites) to inhibit IL-2 consumption during the culture
period. On day4, the supernatant from each culture was as-
sayed for its IL-2 content on HT -2 cells.
bearinginducergrafts (Table III, group2), confirming thatmice reconstituted with
isolated Lyt-2' T cells were capable ofrejecting skin allografts bearing MHC class
I allodeterminants (1-3). Thus, despite the absence ofL3T4' T cells, Lyt-2' anti-
Kbm1 T cells failed to provide help for the activation ofanti-HY effector cells, even
as they were rejecting the K`-bearing inducer grafts. Lyt-2' anti-HYeffector cells
were capable ofrejecting the H-Y indicator grafts when helpwasprovided by L3T4'
Th cells, whether or not K" allodeterminants were present (Table III, groups 3,
4). Finally, it should be pointed out that L3T4' Tcells function as helper cells in
anti-HYresponsesand are themselves incapable ofrejectingthe HY indicatorgrafts
(1, 19).
Lyt-2' Class I-specific Ti,Are Primed by Skin Grafts Expressing Allogeneic Class IDeter-
minants. Because Kbm1 class I allodeterminants failed to activate Th cells able to
induce the rejection ofthird-party skin allografts, it was necessary to ascertain that
MHC class I-allospecific Th cells had in fact recognized and respondedto Kbml class
I allodeterminants expressedby bml inducer skin grafts. To assess the effect, ifany,
ofbml skin allografts on anti-Kbm1 lymphokine-secreting Lyt-2' Th cells, we com-
pared the in vitro IL-2 secretion responses of Lyt-2' Th cells from naive mice and
from mice that had been engrafted with, and had rejected, bml tailskin allografts.
Anti-IL-2-R mAb was added to the in vitro responsecultures to block consumption
of IL-2 during the response period, thereby permitting an accurate and sensitive
measure ofthe IL-2 produced (14, 17). As can be seen in Fig. 2, Lyt-2' Tcells from
mice that had been engrafted with bml skin allografts exhibited a marked shift in
their anti-Kbml dose/response curve in that they required -16-fold fewer stimulator
cells for comparable IL-2 production than did Lyt-2' T cells from naive mice. In
addition, the response of Lyt-2' T cells from burl-engrafted mice was greater at
each stimulator cell dose than that of Lyt-2' T cells from naive mice. That these
effects were specific for Kbmt allodeterminants expressed by the skin allograft is
shown by the failure of Lyt-2' Th from bml-engrafted mice to manifest similarly
increased responses to third-party class I H-2D9 allodeterminants (Fig. 2). Thus,
anti-Kbm1, Lyt-2' lymphokine-secreting Tb are specifically primed by Kbmt class
I disparate skin allografts, demonstrating that Lyt-2' lymphokine-secreting Th cells
do recognize and respond in vivo to class I allodeterminants expressed on skin.
ClassI-specific TCellsConsume theIL-2 They Produce.
￿
Havingdetermined thatLyt-
2' lymphokine-secreting Th cells do respond to MHC class I allodeterminants ex-40
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TABLE IV
Production and Consumption of IL-2 by MHC Class I-reactive T Cells
[3H]TdR incorporation
by HT-2 cells
' M5/114 mAb, 25% culture supernatant (vol/vol).
1 7D4, mAb, 0.01 % ascites (vol/vol).
pressed on skin allografts, it was unclear why MHC class I-disparate inducer skin
allografts did not activate Th cells able to induce rejection of third-party indicator
skin grafts, as did MHC class 11-disparate inducer skin allografts. One possibility
was that lymphokine-secreting Th cells specific for MHC class I or MHC class II
alloantigens differed in the amount of lymphokines that they themselves consumed
andso differed in theamount ofhelper lymphokinesthat they couldprovideto third-
party Tern cells. To compare the amount of soluble IL-2 produced and consumed
by T cells upon recognition of MHC class I and MHC class II allodeterminants,
we measured IL-2 present in supernatants of response cultures under conditions
in which consumptionof IL-2 by respondercells either waspermitted or was blocked
by the presence of anti-IL-2-R mAb (14, 17). It has been previously documented
that anti-IL-2-R mAbfails to stimulatethe secretion ofIL-2 by populations ofMHC
class I-specific lymphokine-secreting Th cells (17). It can be seen in Table IV that
the activity of soluble IL-2 present in the supernatants of response cultures stimu-
lated by recognition of Kbml class I allodeterminants was affected dramatically by
the presence or absence of anti-IL-2-RmAb. Indeed, in the absence of anti-IL-2-R
mAb, essentially all the IL-2 produced in response to recognition of Kbm1 class I
allodeterminants was consumed, whereas that was not the case in response to Ibm12
class II allodeterminants (Table IV, exp. 1). In a second experiment, we added anti-
I-Ab mAb to the response cultures to block activation of Th cells recognizing Kbm1
class I allodeterminants in the context of I-Ab (17, 20), so that we could focus ex-
clusively on anti-Kbm1 class I-restricted Th cells (Table IV, exp. 2). It can be seen
that either in the presence or absence of anti-I-Ab mAb, anti-bml T cells consumed
most of the IL-2 they produced (Table IV, exp. 2). That the anti-I-Ab mAb was
effective in these cultures is indicated by its blockade of the class II-restricted anti-
self response (Table IV, exp. 2). The ability of anti-I-Ab mAb to completely block
L3T4+ class I-specific lymphokine-secreting Th has been previously documented
Exp.
G10 passed
responder
Stimulator
cells
Stimulator cell
antigen
Blocking
mAb' No mAb added
cpm x
Anti-IL-2-R
adddt
10-3
1 B6 Media 1 .2 3 .8
B6 B6 self 3 .3 7.9
B6 bml Kbm) 4.4 47.9
B6 bm12 Ibm12 20.8 41 .2
2 B10 Media - - 0.2 0.6
B10 B10 self - 7.7 14.5
B10 bml Kbml - 2.6 42.7
B10 Media - anti-IAb 0.2 0.5
B10 B10 self anti-IAb 0.1 0.4
B10 bml Kbml anti-IAb 4.8 29.0ROSENBERG ET AL.
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(17). Thus, in contrast to Ibm12 class II-allospecific T cells, K" class I-allospecific
T cells consume essentially all the IL-2 produced.
Discussion
The present study demonstrates that, unlike recognition ofMHC class II allodeter-
minants, recognition ofMHC class I allodeterminants expressed on skin grafts fails
to generate in vivo help for the rejection of third-party skin allografts. That MHC
class I-allospecific Th cells recognize and respond to MHC class I allodeterminants
expressed on skin grafts was shown by the fact that engraftment of mice with class
I-disparate skin specifically primed lymphokine-secreting class I-allospecific Th
cells. However, measurement of the IL-2 produced by class I-allospecific Th cells
in response to MHC class I allodeterminants revealed that the responding cells con-
sumed nearly all the IL-2 that was produced. Taken together, these data are most
consistent with the concept that rejection of skin grafts expressing only class I al-
lodeterminants is mediated by class I-allospecific dual-function Th/Tecc cells that se-
crete IL-2 when activated, but preferentially consume most ofthe helper lymphokines
they secrete.
We have previously shown that the ability to reject skin allografts is not unique
to a specialized subset of T cells of a given phenotype or a given function, since
allograft rejection can result from interactions between distinct populations of
lymphokine-secreting Th cells and lymphokine-responsive T,ff cells that are of
different Lyt phenotypes (1). Indeed, the interacting Th and T,ff cells can even ex-
press distinct antigen specificities, as is the case with Ibm12-specific Th cells activating
Kbm6-specific T effector cells to reject Kbms-disparate skin grafts (1). Thus, interac-
tion with a distinct population of Th cells is one mechanism by which MHC class
I-allospecific T,ff cells can be activated to reject skin allografts expressing MHC
class I allodeterminants. However, these results did not address the possibility that
a second rejection mechanism involving a single subpopulation of dual-function T
cells that both secrete helper lymphokines and differentiate into cytolytic effector
cells might also mediate graft rejection responses without any further cell-cell inter-
action requirements. T cell populations containing dual-function cellswould be read
out as containing both lymphokine-secreting Th cells and lymphokine-responsive
Teff cells and so would be expected to reject skin allografts of appropriate
specificities. Dual-function cells were especially likely to participate in rejection of
class I-disparate skin allografts because: (a) rejection of class I-disparate skin al-
lografts does not require interactions between phenotypically distinct T cell popula-
tions but can be mediated by a single population of Lyt-2' T cells; and (b) T cell
clones with dual function have been shown to be capable of rejecting MHC class
I-disparate pancreatic islet grafts (21) and Lyt-2+ class I-restricted dual-function
cells have been shown capable of rejecting allogeneic tumor grafts (22). However,
it is not known whether T cells with dual-function capability actually play any role
in in vivo allograft rejection responses of normal mice.
To distinguish between the possibilities that class I-disparate skin allografts acti-
vate distinct populations of helper lymphokine-secreting Th cells and lymphokine-
responsive T,ff cells vs. activating a single population of dual-function T cells that
produce their own helper lymphokines, we assessed the ability of T cells reactive
against skin class I allodeterminants to provide help for the rejection ofthird-party42
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skin allografts, in amanner analogousto that provided by MHC classII-allospecific
Th cells. We specifically selected Kbm1 as the stimulatory MHC class I allodeter-
minant for these experiments, because the frequency of anti-Kbm1 lymphokine-
secreting Th cells is higher than for any other class I specificity we have examined
(3, 23), and because the quantity of helper lymphokine produced in anti-Kbm1 re-
sponses is greaterthan foranyother class I-allospecific response we have examined
(23). Even so, we observed a marked disparity in the relative abilities of anti-Kbm1
vs. anti-Ibm12 T cells to provide help for Kbm6- or Qa-1a-specific Te1r cell populations.
The failure of anti-Kbm1 class I-allospecific T cells to provide help for third-party
effector cell populations could have a basis in quantitative or qualitative factors.
It was conceivable that the precursor frequency of Kbml-specific Th cells, as op-
posed to that of Ibm12-specific Th cells, might be insufficient to provide help for third-
party Tern cells. However, previous studies have documented that the frequencies of
anti-Kbm1 and anti-Ibm12 lymphokine-secreting Th cell precursors are comparable
(23, 24).
It was conceivable that MHC class I-allospecific Th cells, while present in the en-
grafted host, did not respond to MHC class I allodeterminants expressed on skin
cells. However, when we compared theresponses ofclass I-allospecific IL-2-secreting
Th cells from mice that had been engrafted with Kbm1 skin allografts with responses
ofcells from naive mice, we found that anti-Kbm1 lymphokine-secreting Tcells were
clearly primed by engraftment with bml skin. Thus, class I-allospecific Th cells do
recognize and respondto MHC class I allodeterminants expressedon skin allografts.
Finally, it was conceivable that class I-allospecific Th cells might secretevery little
lymphokine on a cell for cell basis, or alternatively, that classI-alloresponsive Tcells
might consume greater amounts of lymphokine than do class II-alloresponsive T
cells. We addressed these points by stimulating anti-class I lymphokine responses
in vitro and comparing the amount of soluble lymphokine secreted into the media
when the consumption of these factors was either blocked or not. It was clear that
the anti-class I lymphokine response was substantial when lymphokine consump-
tion was blocked, but that when consumption was not blocked, the class I-reactive
Tcellsconsumed nearly all ofthesolublelymphokine produced, leavinglittle soluble
lymphokine in the medium. Thus, we think the failure of class I allodeterminants
to provide help in vivo for activating third-party effector cells is dueto the fact that
lymphokine-secreting T cells reactive to class I allodeterminants on skin grafts con-
sume most of the helper lymphokines they produce. This property is precisely that
expected of dual-function Th/Tef cells and so indicates that rejection of skin al-
lografts expressing only class I disparities can be mediated by dual-function T cells
that preferentially consume the helper factors they secrete. This conclusion is en-
tirely consistent with previous work demonstrating that only Tcell populationscon-
taining both Th and Terr cellular functions are able to mediate graft rejection (1).
Thus, Th and Tern cellular functions may be generated by distinct, interacting cel-
lularpopulations, or maybe generated by a single population ofdual-function cells.
The observation that MHC class I allodeterminants fail to trigger T cell help for
the in vivo activation of Tern cells with third-party specificities sharplycontrasts with
their ability to do so in vitro (25). Dual-function T cells appear similar to conven-
tional Th cells in that they secrete soluble helper lymphokines. Dual-function T cells
are also similar to conventional Terr cells in that they bind soluble lymphokine toROSENBERG ET AL.
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specific receptors on the cell surface, and this bindingis susceptible to blockade by
anti-receptorantibody. Thus, the primary advantage that dual-function T cellshave
over conventional helper-dependent Teff cells is that the dual-function cell is neces-
sarily more proximal to the secreted lymphokines. We thinkthat the proximity ad-
vantage is largelynegated in vitrowhere Tcell subpopulations areartificially brought
together. In contrast, proximity advantages are likely to be of critical importance
in vivo, where T cellshave to migrate to thereaction site, particularly when secreted
helper lymphokine is present in limiting amounts.
Taken together, these data demonstrate that there are two Tern cell populations
able to mediate the rejection of MHC class I-disparate skin grafts. There are class
I-specific effector cells, such as anti-Kbms effector cells, that are themselves unable
to secrete lymphokine but can use exogenous T cell help to become activated and
reject bm6 skin allografts. In addition, there are class I-specific effector cells, such
as anti-Kb-1 effector cells, that produce and consume their own Th factors in re-
sponse to skin grafts expressing Kbm1 allodeterminants. Thus, MHC class I-dis-
parate grafts can be rejected by two cellular mechanisms depending on the ability
of the Teen cell population to secrete lymphokine in response to class I alloantigen:
(a) a dual-function cell mechanism and (b) a mechanism requiring an interaction
between distinct populations of lymphokine-secreting Th cells and lymphokine-
responsive Teen cells.
Summary
The present study further characterizes the cellular mechanisms involved in the
in vivo rejection of MHC class I-disparate skin allografts. Previously, we demon-
strated that class I-specific rejectionresponsescouldresult from collaborations between
distinct populations of lymphokine-secreting T helper (Th) and lymphokine-
responsive T effector (Teff) cells. In the present study, we have assessed the possi-
bility that class I-specific rejectionresponses could also result from a second cellular
mechanism involving a single population of dual-function Th/Teff cells that would
nothave anyfurtherrequirementforcell-cellcollaboration. Ourexperimental strategy
was to determine the ability of MHC classI-allospecific T cells, in response to class
I allodeterminants expressed on skin grafts, to provide help in vivo for activation
of helper-dependent Teff cells. We found that class I anti-Kbme_allospecific T cells
would reject bml skin allografts, but would not generate help for the activation of
helper-dependent effector cells that were specific for third-party skin allografts (e.g.,
grafts expressing Kbms, Qala, or HY allodeterminants). This failure of anti-Kbm'
T cells to provide help in response to bml skin allografts was not due to an inability
oflymphokine-secreting anti-Kbm' Th cells to recognize and respond in vivo to Kbm1
allodeterminants expressed on skin, since lymphokine-secreting anti-Kb,' Th cells
were specifically primed in animals engrafted with bml skin allografts. Nor was any
evidence found that this failure was due to active suppression of anti-Kbm' helper
activity. Rather, we found that anti-Kbm' T cells consumed nearly all of the helper
factors they secreted. Taken together, these results are most consistent with the in
vivo activity of dual-function Th/Teff cells that consume the lymphokines they
secrete.
Thus, this study demonstrates that MHC class I-disparate skin allografts canbe44
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rejected by two mechanisms, depending on the ability of the allospecific Tefr cell
to secrete helper lymphokines. MHC class I-disparate grafts can be rejected by (a)
class I-allospecific Tern cells that are unable to produce lymphokine but are respon-
sive to exogenous T cell help; and (b) class I-allospecific dual-function Th/Terr cells
that are able to both produce and consume soluble lymphokine.
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